Logo image of ULBI

ULTRALIFE CORP (ULBI) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:ULBI - US9038991025 - Common Stock

5.4 USD
-0.25 (-4.42%)
Last: 12/8/2025, 4:30:02 PM
Fundamental Rating

5

Taking everything into account, ULBI scores 5 out of 10 in our fundamental rating. ULBI was compared to 90 industry peers in the Electrical Equipment industry. Both the profitability and the financial health of ULBI get a neutral evaluation. Nothing too spectacular is happening here. ULBI may be a bit undervalued, certainly considering the very reasonable score on growth


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year ULBI was profitable.
In the past year ULBI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ULBI reported negative net income in multiple years.
Of the past 5 years ULBI 4 years had a positive operating cash flow.
ULBI Yearly Net Income VS EBIT VS OCF VS FCFULBI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M

1.2 Ratios

ULBI has a better Return On Assets (0.77%) than 68.89% of its industry peers.
ULBI has a better Return On Equity (1.25%) than 68.89% of its industry peers.
ULBI has a Return On Invested Capital of 3.23%. This is in the better half of the industry: ULBI outperforms 64.44% of its industry peers.
ULBI had an Average Return On Invested Capital over the past 3 years of 3.14%. This is significantly below the industry average of 9.93%.
The last Return On Invested Capital (3.23%) for ULBI is above the 3 year average (3.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.77%
ROE 1.25%
ROIC 3.23%
ROA(3y)2.28%
ROA(5y)2.1%
ROE(3y)3.46%
ROE(5y)2.93%
ROIC(3y)3.14%
ROIC(5y)N/A
ULBI Yearly ROA, ROE, ROICULBI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

ULBI has a better Profit Margin (0.92%) than 71.11% of its industry peers.
In the last couple of years the Profit Margin of ULBI has declined.
ULBI has a better Operating Margin (4.20%) than 66.67% of its industry peers.
ULBI's Operating Margin has been stable in the last couple of years.
ULBI has a Gross Margin (23.89%) which is in line with its industry peers.
ULBI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.2%
PM (TTM) 0.92%
GM 23.89%
OM growth 3YN/A
OM growth 5Y-0.24%
PM growth 3YN/A
PM growth 5Y-4.65%
GM growth 3Y0.93%
GM growth 5Y-2.51%
ULBI Yearly Profit, Operating, Gross MarginsULBI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

4

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ULBI is destroying value.
Compared to 1 year ago, ULBI has more shares outstanding
The number of shares outstanding for ULBI has been increased compared to 5 years ago.
Compared to 1 year ago, ULBI has a worse debt to assets ratio.
ULBI Yearly Shares OutstandingULBI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ULBI Yearly Total Debt VS Total AssetsULBI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.2 Solvency

Based on the Altman-Z score of 1.77, we must say that ULBI is in the distress zone and has some risk of bankruptcy.
ULBI's Altman-Z score of 1.77 is in line compared to the rest of the industry. ULBI outperforms 55.56% of its industry peers.
ULBI has a debt to FCF ratio of 5.62. This is a neutral value as ULBI would need 5.62 years to pay back of all of its debts.
ULBI has a Debt to FCF ratio of 5.62. This is in the better half of the industry: ULBI outperforms 71.11% of its industry peers.
ULBI has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.34, ULBI perfoms like the industry average, outperforming 53.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 5.62
Altman-Z 1.77
ROIC/WACC0.45
WACC7.19%
ULBI Yearly LT Debt VS Equity VS FCFULBI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

2.3 Liquidity

ULBI has a Current Ratio of 2.99. This indicates that ULBI is financially healthy and has no problem in meeting its short term obligations.
ULBI has a better Current ratio (2.99) than 75.56% of its industry peers.
ULBI has a Quick Ratio of 1.42. This is a normal value and indicates that ULBI is financially healthy and should not expect problems in meeting its short term obligations.
ULBI has a Quick ratio (1.42) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.99
Quick Ratio 1.42
ULBI Yearly Current Assets VS Current LiabilitesULBI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

6

3. Growth

3.1 Past

ULBI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -77.78%.
The Earnings Per Share has been growing slightly by 3.31% on average over the past years.
ULBI shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.94%.
ULBI shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 9.02% yearly.
EPS 1Y (TTM)-77.78%
EPS 3YN/A
EPS 5Y3.31%
EPS Q2Q%-450%
Revenue 1Y (TTM)12.94%
Revenue growth 3Y18.71%
Revenue growth 5Y9.02%
Sales Q2Q%21.51%

3.2 Future

Based on estimates for the next years, ULBI will show a very strong growth in Earnings Per Share. The EPS will grow by 43.60% on average per year.
Based on estimates for the next years, ULBI will show a quite strong growth in Revenue. The Revenue will grow by 18.34% on average per year.
EPS Next Y68.52%
EPS Next 2Y43.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year31.82%
Revenue Next 2Y18.34%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ULBI Yearly Revenue VS EstimatesULBI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
ULBI Yearly EPS VS EstimatesULBI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.2 0.4 0.6 0.8

7

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 38.57, ULBI can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of ULBI indicates a somewhat cheap valuation: ULBI is cheaper than 70.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 26.34. ULBI is valued slightly more expensive when compared to this.
Based on the Price/Forward Earnings ratio of 5.69, the valuation of ULBI can be described as very cheap.
Based on the Price/Forward Earnings ratio, ULBI is valued cheaply inside the industry as 98.89% of the companies are valued more expensively.
ULBI is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.56, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 38.57
Fwd PE 5.69
ULBI Price Earnings VS Forward Price EarningsULBI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

92.22% of the companies in the same industry are more expensive than ULBI, based on the Enterprise Value to EBITDA ratio.
95.56% of the companies in the same industry are more expensive than ULBI, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 10.04
EV/EBITDA 10.24
ULBI Per share dataULBI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

ULBI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ULBI's earnings are expected to grow with 43.60% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.56
PEG (5Y)11.67
EPS Next 2Y43.6%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ULBI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ULTRALIFE CORP

NASDAQ:ULBI (12/8/2025, 4:30:02 PM)

5.4

-0.25 (-4.42%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)11-18 2025-11-18/bmo
Earnings (Next)03-09 2026-03-09
Inst Owners73.05%
Inst Owner Change-2.65%
Ins Owners3.19%
Ins Owner Change0.56%
Market Cap89.91M
Revenue(TTM)186.53M
Net Income(TTM)1.72M
Analysts82.86
Price Target14.28 (164.44%)
Short Float %0.65%
Short Ratio2.02
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-91.09%
Min EPS beat(2)-131.19%
Max EPS beat(2)-50.98%
EPS beat(4)0
Avg EPS beat(4)-72.67%
Min EPS beat(4)-131.19%
Max EPS beat(4)-15.03%
EPS beat(8)3
Avg EPS beat(8)-15.66%
EPS beat(12)5
Avg EPS beat(12)43.11%
EPS beat(16)7
Avg EPS beat(16)38.76%
Revenue beat(2)0
Avg Revenue beat(2)-13.21%
Min Revenue beat(2)-19.77%
Max Revenue beat(2)-6.65%
Revenue beat(4)2
Avg Revenue beat(4)-3.82%
Min Revenue beat(4)-19.77%
Max Revenue beat(4)7.48%
Revenue beat(8)5
Avg Revenue beat(8)-1.68%
Revenue beat(12)7
Avg Revenue beat(12)2.25%
Revenue beat(16)10
Avg Revenue beat(16)3.31%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 38.57
Fwd PE 5.69
P/S 0.48
P/FCF 10.04
P/OCF 7.17
P/B 0.66
P/tB 1.31
EV/EBITDA 10.24
EPS(TTM)0.14
EY2.59%
EPS(NY)0.95
Fwd EY17.57%
FCF(TTM)0.54
FCFY9.96%
OCF(TTM)0.75
OCFY13.96%
SpS11.2
BVpS8.24
TBVpS4.12
PEG (NY)0.56
PEG (5Y)11.67
Graham Number5.1
Profitability
Industry RankSector Rank
ROA 0.77%
ROE 1.25%
ROCE 4.15%
ROIC 3.23%
ROICexc 3.4%
ROICexgc 5.52%
OM 4.2%
PM (TTM) 0.92%
GM 23.89%
FCFM 4.8%
ROA(3y)2.28%
ROA(5y)2.1%
ROE(3y)3.46%
ROE(5y)2.93%
ROIC(3y)3.14%
ROIC(5y)N/A
ROICexc(3y)3.31%
ROICexc(5y)N/A
ROICexgc(3y)5.27%
ROICexgc(5y)N/A
ROCE(3y)4.03%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5Y2.06%
ROICexc growth 3YN/A
ROICexc growth 5Y-0.19%
OM growth 3YN/A
OM growth 5Y-0.24%
PM growth 3YN/A
PM growth 5Y-4.65%
GM growth 3Y0.93%
GM growth 5Y-2.51%
F-Score3
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 5.62
Debt/EBITDA 3.52
Cap/Depr 66.95%
Cap/Sales 1.93%
Interest Coverage 250
Cash Conversion 95.05%
Profit Quality 521.01%
Current Ratio 2.99
Quick Ratio 1.42
Altman-Z 1.77
F-Score3
WACC7.19%
ROIC/WACC0.45
Cap/Depr(3y)49.8%
Cap/Depr(5y)66.84%
Cap/Sales(3y)1.35%
Cap/Sales(5y)1.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-77.78%
EPS 3YN/A
EPS 5Y3.31%
EPS Q2Q%-450%
EPS Next Y68.52%
EPS Next 2Y43.6%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.94%
Revenue growth 3Y18.71%
Revenue growth 5Y9.02%
Sales Q2Q%21.51%
Revenue Next Year31.82%
Revenue Next 2Y18.34%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-36.81%
EBIT growth 3YN/A
EBIT growth 5Y8.76%
EBIT Next Year101.77%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y3629.58%
FCF growth 3Y113.07%
FCF growth 5YN/A
OCF growth 1Y506.14%
OCF growth 3Y56.62%
OCF growth 5YN/A

ULTRALIFE CORP / ULBI FAQ

What is the ChartMill fundamental rating of ULTRALIFE CORP (ULBI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ULBI.


Can you provide the valuation status for ULTRALIFE CORP?

ChartMill assigns a valuation rating of 7 / 10 to ULTRALIFE CORP (ULBI). This can be considered as Undervalued.


Can you provide the profitability details for ULTRALIFE CORP?

ULTRALIFE CORP (ULBI) has a profitability rating of 5 / 10.


How financially healthy is ULTRALIFE CORP?

The financial health rating of ULTRALIFE CORP (ULBI) is 4 / 10.